Robinhood CFO Says OpenAI Access Is Next for Retail Investors

—

When Gum Sales Spike, What’s Really Happening?

It’s not just your imagination. Sales of gum and mints are up — and not because people suddenly crave minty freshness.

According to Hershey CEO Kirk Tanner, demand for gum and mints is strong — and it’s being fueled by the rise of GLP-1 weight-loss drugs. These drugs cause patients to feel full faster. So, they’re chewing gum to manage hunger and oral habits.

That’s a real shift. It’s not just a trend. It’s a behavioral change driven by medicine. And it’s showing up in sales numbers.

Back in April, Hershey reported first-quarter results that beat analyst expectations. Sales were higher. Prices were up. And the gum and mint category? Still growing.

So what does this mean for you? If you’ve been skipping meals or cutting back on snacks, you’re not alone. But the real story isn’t just about appetite control. It’s about how new health trends are reshaping everyday purchases.

And here’s the kicker: that same shift in behavior is now influencing how investors think about tech.

—

From Gum to AI: The New Retail Power Play

Think about it. A company like Hershey sees a spike in gum sales — not because of a new flavor, but because of a medical trend. That’s real-world data. Real impact.

Now, imagine that same kind of demand — but for something even bigger: artificial intelligence.

Robinhood’s CFO recently said the company is exploring ways to give retail investors access to OpenAI. That’s not just a rumor. It’s a signal. The idea is that everyday investors want to get in on the ground floor of the next big thing — just like they’re buying gum because of a health trend.

But why now? Because the rules are changing.

Back in April, CNBC reported that investors priced out of the NFL and NBA are now looking at smaller leagues. Why? Because the cost of owning a team is skyrocketing. A single NBA franchise? Valued at over $5 billion. That’s not a game for most people.

But what if you could own a piece of the next big AI company — not as a billionaire, but as a regular investor?

That’s the dream. And it’s becoming real.

Anthropic, a major AI rival to OpenAI, is reportedly in talks to raise funds at a $900 billion valuation. That’s bigger than the current market cap of many Fortune 500 companies.

So, if you’re a retail investor, you’re asking: “Can I get in? Can I own a piece of this?”

And the answer? Maybe. But not through the old way.

—

Why the IPO Rush Is More Than Just Hype

SpaceX is preparing for an IPO. That’s huge. The company has filed confidential paperwork with regulators. It’s reportedly targeting a $1.75 trillion valuation.

That’s not a typo. $1.75 trillion. That would make it one of the most valuable companies ever.

But here’s the thing: SpaceX isn’t just a rocket company. It’s a tech powerhouse. It owns xAI, Elon Musk’s AI division. And it just struck a deal to buy AI company Cursor.

That’s not just expansion. That’s consolidation. SpaceX is building an AI empire — and it’s doing it fast.

So why does this matter to you?

Because when a company like SpaceX goes public, it’s not just about buying stock. It’s about access. It’s about being part of something that’s shaping the future.

And now, retail investors are saying: “We want in.”

Robinhood’s CFO isn’t just talking about access. He’s talking about a new era — where regular people can get into the same deals that hedge funds once controlled.

Look at it this way: A few years ago, only institutions could buy into AI startups. Now, you might be able to do it through your phone.

But here’s the real question: Is this a fair chance? Or is it just another bubble?

Let’s be honest. The market is full of hype. But it’s also full of real innovation.

And when you see sales of gum rising because of a medical trend — and sales of AI startups soaring because of investor demand — you start to see a pattern.

People aren’t just buying products. They’re buying into ideas.

—

What’s Behind the Surge in Demand?

It’s not just about money. It’s about control.

When you watch the NFL, you see teams worth billions. But you don’t own a piece of them. You just watch.

But now, investors are asking: “Can I own a stake in a team? A team in a lower league? A team that’s not yet a household name?”

Yes. And that’s the shift.

It’s not just about buying into big brands. It’s about buying into potential.

Take GLP-1 drugs. Eli Lilly’s stock nearly doubled in April, driven by sales growth. That’s real momentum. And it’s not just the drug. It’s the behavior it’s changing.

People are using these drugs. They’re skipping meals. They’re chewing gum. They’re making choices they didn’t make before.

And that’s creating demand — not just for pills, but for products that help manage the side effects.

So when Hershey says sales of gum and mints are up, it’s not just a report. It’s a signal. It’s proof that real life is changing — and markets are responding.

Now, imagine that same energy — but for AI.

That’s what’s happening with OpenAI. And that’s why Robinhood is thinking about giving retail investors access.

It’s not just about money. It’s about being part of the next wave.

And here’s the kicker: You don’t need to be a billionaire to get in. You just need to want in.

But is it too late? Or is this just the beginning?

—

What Should You Watch For?

Let’s be clear: This isn’t just a trend. It’s a transformation.

When you see a company like SpaceX aiming for a $1.75 trillion valuation, you’re not just looking at a rocket. You’re looking at a tech empire. And it’s going public.

When you see Anthropic aiming for a $900 billion valuation, you’re not just seeing a startup. You’re seeing a rival to OpenAI — one that could shape the future of AI.

And when you see Hershey’s CEO say demand for gum and mints is strong, you’re not just hearing about candy. You’re hearing about human behavior — and how it’s changing.

So what should you watch for?

First: The timing of SpaceX’s IPO. It’s expected in June. That’s not far off. And when it happens, it could set the tone for how AI companies are valued.

Second: How Robinhood actually delivers on OpenAI access. Is it through a direct investment? A fund? A platform feature? That’s the real test.

Third: The flow of capital. Are more investors moving into AI? Are they betting on startups that aren’t household names? That’s where the real action is.

And finally: How sales trends like gum and mint growth are being tracked. Because if a health trend can boost candy sales, it can also boost investor confidence in new markets.

So yes — you should care. Because this isn’t just about stocks. It’s about who gets to be part of the future.

And if you’re a regular investor, that future might just be closer than you think.

—

Final Thoughts: The Real Shift Isn’t in the Price — It’s in the Access

I remember walking into a coffee shop last week. The barista was chewing gum. Not because she liked it. But because she’s on a GLP-1 drug. She told me she’s lost 15 pounds. And she’s been chewing gum to stay full.

That’s not a story from a news report. That’s real life.

And it’s connected to what’s happening in the markets.

When you see a CEO like Kirk Tanner say demand for gum is strong, you’re not just hearing about sales. You’re hearing about change.

And when you see Robinhood’s CFO talk about OpenAI access, you’re not just hearing about a new product. You’re hearing about power.

Power to invest. Power to be part of something big.

So yes — sales matter. But the bigger story is about who gets to be part of the next chapter.

And that’s what you should watch for.

Because the future isn’t just for billionaires. It’s for you.

—

**

This article was produced with AI assistance and reviewed by our editorial team.

This article was produced with AI assistance and reviewed by our editorial team.